Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical 
function in gastric cancer

Carvalho, S.; Catarino, T. A.; Dias, A. M.; Kato, M.; Almeida, A.; Hessling, B.; Figueiredo, J.; Gaertner, F.; Sanches, J. M.; Ruppert, T.; Miyoshi, E.; Pierce, M.; Carneiro, F.; Kolarich, D.; Seruca, R.; Yamaguchi, Y.; Taniguchi, N.; Reis, C. A.; Pinho, S. S.

doi:10.1038/onc.2015.225

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2286713_4

DetailsSummary

Released

Journal Article

Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer

MPS-Authors

/persons/resource/persons188000

Almeida, A.
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121498

Kolarich, D.
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

2286713_supp1.doc
(Supplementary material), 4MB

2286713_supp2.xls
(Supplementary material), 255KB

2286713_supp3.xls
(Supplementary material), 45KB

Citation

Carvalho, S., Catarino, T. A., Dias, A. M., Kato, M., Almeida, A., Hessling, B., et al. (2016). Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer. Oncogene, 35(13), 1619-1631. doi:10.1038/onc.2015.225.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-8B72-C

Abstract

There is no abstract available